Press

High-Tech Gründerfonds and Technologiegründerfonds Sachsen support enabling human biology in vitro with an investment in Dresden start-up denovoMATRIX

December 11, 2018

denovoMATRIX develops and manufactures biomimetic coatings for stem cell culture. With its technology, the team of denovoMATRIX enables cutting edge research in the stem cell field, and aims to revolutionize cell culture processes in Life Science research. The HTGF together with TGFS are participating in the seed financing round to support the growing denovoMATRIX team, and the launch of denovoMATRIX products into the market.

In recent months, denovoMATRIX has received great feedback and support from industry experts, winning the Innovation prize from IQ-Mitteldeutschland Life Science Cluster. ‘’Although we are pleased with our performance at various businessplan competitions, we are currently focusing our attention on our myMATRIX product line, designed for streamlining cell culture processes using defined, serum-free conditions’’ explains the CEO of denovoMATRIX, Dejan Husman. The start-up already has their first product line – the screenMATRIX – available for purchase through their website. It is a tool designed for researchers interested in discovering the ideal conditions for culturing their cells.

Dr. Fabian Mohr, Investment Manager at HTGF: “In order to be able to offer high-quality stem cell therapies in the future, manufacturers must keep their variability in cell cultivation low. denovoMATRIX products offer a chemically defined solution to this problem, which we hope will provide a good basis for the translation of stem cell therapies from research into clinical practice.”

About denovoMATRIX
In August 2018, denovoMATRIX GmbH was founded as a spin-off of the Technical University of Dresden. With the support of the Bundesministerium für Wirtschaft und Energie (BMWi) funding program EXIST Transfer of Research, the founders were able to commercialize the technology developed at the B CUBE – Center for Molecular Bioengineering. The vision of denovoMATRIX is to enable human biology in vitro – a broad mission to foster research in cell culture, and accelerate the implementation of cell-based therapies for the treatment of diseases.

Contact
denovoMATRIX GmbH
Christian Woiwod
Tatzberg 47/49
01307 Dresden
mail@denovomatrix.com
www.denovomatrix.com

About High-Tech Gründerfonds
High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven start-ups. With EUR 892.5 million in total investment volume across three funds and an international network of partners, HTGF has already helped forge 500 start-ups since 2005. Driven by their expertise, entrepreneurial spirit and passion, its team of experienced investment managers and start-up experts help guide the development of young companies. HTGF’s focus is on high-tech start-ups in a range of sectors, including software, hardware and life sciences / chemistry.
This group also includes a number of success stories, such as Mister Spex, Rigontec, 6Wunderkinder, Next Kraftwerke and Cumulocity, as well as Juniqe, an online shop for art enthusiasts. To date, external investors have injected over EUR 1.9 billion into the HTGF portfolio via about 1,400 follow-on financing rounds. HTGF has also successfully sold interests by now 100 companies. Investors in this public-private partnership include the Federal Ministry For Economic Affairs and Energy, the KfW Banking Group, and Fraunhofer-Gesellschaft e.V., as well as the companies ALTANA, BASF, BAYER, B.Braun, Boehringer Ingelheim, Robert Bosch, BÜFA, CEWE, Deutsche Post DHL, Dräger, Drillisch AG, EVONIK, EWE AG, Haniel, Hettich, Knauf, Körber, LANXESS, media + more venture Beteiligungs GmbH & Co. KG, PHOENIX CONTACT, Postbank, QIAGEN, RWE Generation SE, SAP, Schufa, Schwarz Gruppe, STIHL, Thüga, Vector Informatik, WACKER and Wilh. Werhahn KG.

Contact
High-Tech Gründerfonds Management GmbH
Dr. Fabian Mohr
Schlegelstraße 2
53113 Bonn / Germany
T: +49 228 82300 181
f.mohr@htgf.de
www.htgf.de

More Press posts

26. November 2021

ZE ENERGY raises €40m in a new funding round

Paris, France, 26 November 2021 - Less than two years after its creation and following the completion of a first seed round of funding worth €5.2M, ZE ENERGY, a French independent renewable energy producer operating hybrid solar power plants (photovoltaic and storage), announces the completion of a €40M Series B round of funding that will help bring the company to new heights. Backed by its initial investors, DEMETER, High-Tech Gründerfonds (HTGF), EverWatt and Ze Way Invest, the co
 
24. November 2021

Capital for Quantum cooling – kiutra closes another financing round

Munich, November 24th 2021 - To calculate and solve complex problems faster than currently possible with supercomputers, to exchange information securely against eavesdropping and to determine physical quantities such as pressure, time, position, speed and magnetic fields with unprecedented accuracy: These promises and more combined with an immense economic potential are some of the possibilities of the second generation of quantum technologies. As extremely low temperatures, close to th
 
18. November 2021

Operaize receives €1.5 million in seed capital to increase production efficiency and sustainability by leveraging AI

Cologne, November, 18th 2021 – Cologne-based start-up Operaize has successfully closed a seed financing round with three investors: High-Tech Gründerfonds (HTGF), Fraunhofer Technologie-Transfer Fonds (FTTF) and NRW.BANK invest a total of 1.5 million euros in Operaize to accelerate the development of the AI-based product, drive the product market fit and to acquire new customers. Operaize provides AI-based production planning that enables manufacturers to better manage the increasing c